Simona Carnio

Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%

Alessio Cortellini, Marcello Tiseo, Giuseppe Luigi Banna et al. · Cancer Immunology Immunotherapy · 2020 · 93 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics

Laura Mezquita, Isabel R. Preeshagul, Édouard Auclin et al. · European Journal of Cancer · 2021 · 60 citations · Full text

Medicine, Immunology, Oncology +12

Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study

Alessio Cortellini, Katia Cannita, Marcello Tiseo et al. · European Journal of Cancer · 2021 · 31 citations · Full text

Medicine, Oncology, Pharmacology +14

Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG

Melissa Bersanelli, Diana Giannarelli, Ugo De Giorgi et al. · Therapeutic Advances in Medical Oncology · 2020 · 24 citations · Full text

Veterinary Medicine, Immunology, Oncology +16

Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority Study

Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni et al. · The Oncologist · 2021 · 24 citations · Full text

Pharmacy, Oncology, Pharmacology +16